Results 191 to 200 of about 1,862,216 (244)

Recurrent subacute stent thrombosis after drug-eluting stent implantation: a case report. [PDF]

BMC Cardiovasc Disord
Yang Y, Jiang J, Chen Z, Fan C.
europepmc   +1 more source

From Mechanisms to Management: Tackling In-Stent Restenosis in the Drug-Eluting Stent Era. [PDF]

Curr Cardiol Rep
Spadafora L, Quarta R, Martino G, Romano L, Greco F, Curcio A, Gori T, Spaccarotella C, Indolfi C, Polimeni A.   +9 more
europepmc   +1 more source

Comparison of the efficacy of intravascular lithotripsy and rotational atherectomy as adjunctive therapy before drug-eluting stent implantation in calcified coronary lesions (CCS- Coronary Calcification Study). [PDF]

BMC Cardiovasc Disord
Pleva L, Kukla P, Konde A.
europepmc   +1 more source

Drug-coated balloon vs drug-eluting stent in de novo coronary lesions: a propensity score matched cohort study. [PDF]

Clin Res Cardiol
Baumer U, Steinacher E, Hammer A, Kazem N, Hofer F, Frey B, Lang I, Hengstenberg C, Hemetsberger R, Sulzgruber P, Niessner A, Koller L.   +11 more
europepmc   +1 more source

Drug-coated balloon angioplasty or drug-eluting stent implantation? a focus after the REC-CAGEFREE1 trial. [PDF]

Eur Heart J Suppl
Leone PP, Colombo A.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Drug-Eluting Stents

Seminars in Interventional Radiology, 2022
AbstractEndovascular revascularization strategies have advanced tremendously over the years and are now often considered first line for treatment of peripheral arterial disease. Drug-eluting stents (DESs) have been developed as one of the tools to overcome the limitations of elastic recoil and neointimal hyperplasia observed with balloon angioplasty ...
Chetan, Velagapudi, Sreekumar, Madassery
openaire   +2 more sources

Drug-Eluting Stents

Annual Review of Medicine, 2004
Advances in catheter and stent design have made stent implantation the standard coronary angioplasty procedure. Unfortunately, in-stent restenosis continues to plague this procedure, with the optimum binary restenosis rates reaching ∼10% to 20%. In the past few years, it has become clear that in-stent restenosis is largely due to the migration and ...
Porto I, Banning AP
openaire   +5 more sources

Stents and Drug-Eluting Stents

Otolaryngologic Clinics of North America, 2009
Synechiae and ostial stenosis are common and troublesome complications following endoscopic sinus surgery. Many investigators have advocated the use of stents to minimize the risk of postoperative stenosis while others have found their use to be of no benefit. This article reviews the advantages and disadvantages of various stents used in sinus surgery,
Karen A, Bednarski, Frederick A, Kuhn
openaire   +2 more sources

An Update on Drug-Eluting Stents

Current Treatment Options in Cardiovascular Medicine, 2012
Coronary artery disease remains one of the major causes of morbidity and mortality worldwide. Percutaneous coronary intervention has been shown to be an effective treatment for angina pectoris, although it does not provide any prognostic benefit in stable patients.
Garg, Scot, Serruys, PWJC (Patrick)
openaire   +3 more sources

In-stent Restenosis of drug-eluting Stents

Future Cardiology, 2013
Drug-eluting stents (DES) have emerged as an improved alternative to bare-metal stents by demonstrating reduced rates of restenosis and target lesion revascularization. This emergence has led to the unrestricted use of DES for various indications and lesions, and subsequently revealed DES in-stent restenosis as a novel interventional therapeutic ...
Sa'ar, Minha, Augusto D, Pichard, Ron, Waksman   +2 more
openaire   +2 more sources